Results 181 to 190 of about 3,669,569 (215)

Pharmacological chromatin remodeling enhances response to estrogen therapy in ER+ breast cancer

open access: yesMolecular Oncology, EarlyView.
Estrogen therapy elicits clinical benefit in ~ 30% of patients with endocrine‐resistant estrogen receptor (ER)‐positive breast cancer. Based on findings that ER transcriptional activation underlies response to estrogen therapy, we tested the effects of epigenetic dysregulation via pharmacological inhibition of histone deacetylases (HDACi).
Anneka L. Johnson Thomas   +16 more
wiley   +1 more source

Gabapentin Use in Medicaid After Descheduling.

open access: yesJAMA Netw Open
Gora Combs K   +3 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy